u/Waracken

Entropy Neurodynamics expanding into Anorexia Nervosa, Body Dysmorphic Disorder, OCD, GAD, PTSD, TRD, Fibromyalgia, and IBS.

One of my favorite lesser known companies in the sector!

Phase 2 data for BED for cohort 2 coming Q4 this year.

I’m surprised there’s almost no discussion of Island Pharmaceuticals here. The company has secured approvals to deploy galidesivir under the WHO MEURI framework during the Bundibugyo Ebola outbreak, potentially generating prospective human data alongside its FDA Animal Rule program, with multiple studies and NDA preparation targeted through 2027. It’s obviously still speculative, but a broad-filovirus antiviral with historical NIAID/BARDA support, no debt and several upcoming catalysts seems worthy of more attention.

Not to mention, a fantastic team at the helm leading the way.